Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7326
    +0.0003 (+0.04%)
     
  • CRUDE OIL

    83.82
    +0.25 (+0.30%)
     
  • Bitcoin CAD

    88,173.30
    +480.16 (+0.55%)
     
  • CMC Crypto 200

    1,389.68
    +7.11 (+0.51%)
     
  • GOLD FUTURES

    2,347.00
    +4.50 (+0.19%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,772.75
    +205.25 (+1.17%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,811.83
    +183.35 (+0.49%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

1 "Safe" Stock to Avoid and 1 to Consider Buying in April

1 "Safe" Stock to Avoid and 1 to Consider Buying in April

Many investors have had the unpleasant experience of buying shares of a company they thought was safe, only to see their money evaporate down the line when their investment wasn't as "safe" as their initial impressions. In that vein, one of the hallmarks of safety is reliable and highly recurring revenue and earnings, complete with a durable and defensible profit margin that's consistent over time. Manufacturers of generic pharmaceuticals seem to fit that bill.